Clinical Trial Results:
            A single-centre, randomised, 2 way crossover, double blind, placebo controlled study in healthy volunteers, to characterise the antacid activity of Gaviscon Double Action Mint Liquid in the fasted state, using a novel intragastric and oesophageal pH catheter.
    
|     Summary | |
|     EudraCT number | 2012-004131-23 | 
|     Trial protocol | GB | 
|     Global completion date | |
|     Paediatric regulatory details | |
|     Is the trial part of an agreed EMA paediatric investigation plan? | |
|     Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | |
|     Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | |
|     Results information | |
|     Results version number | v1(current) | 
|     This version publication date | 
                                    25 Jun 2022
                             | 
|     First version publication date | 
                                    25 Jun 2022
                             | 
|     Other versions | |
|     Summary report(s) | GA1212 early termination | 
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.    
 
				
